MDGL - Madrigal Pharmaceuticals Q1 2024 Earnings Preview
2024-05-06 10:57:03 ET
More on Madrigal Pharmaceuticals
- Madrigal: Rezdiffra Launch Gets Underway, The Only Competition Is Off-Label
- Madrigal: 2 Challenges To Overcome To Maintain NASH 'First Mover' Advantage
- Madrigal: Accelerated Rezdiffra Approval Puts It In The NASH Lead
- Madrigal announces US launch of NASH/MASH drug Rezdiffra
- Madrigal Pharmaceuticals commences underwritten public offering